KeyBank National Association
TEVA icon

KeyBank National Association’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

KeyBank National Association’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Buy
20,532
+2,138
+12% +$71.2K ﹤0.01% 776
2026
Q1 		$554K Buy
18,394
+10,019
+120% +$322K ﹤0.01% 785
2025
Q4 		$261K Buy
+8,375
New +$206K ﹤0.01% 1066
2018
Q1 		– Sell
-15,792
Closed -$299K – 1089
2017
Q4 		$299K Sell
15,792
-15,391
-49% -$232K ﹤0.01% 895
2017
Q3 		$549K Sell
31,183
-4,954
-14% -$111K ﹤0.01% 748
2017
Q2 		$1.2M Sell
36,137
-8,387
-19% -$260K 0.01% 526
2017
Q1 		$1.43M Sell
44,524
-4,328
-9% -$148K 0.01% 471
2016
Q4 		$1.77M Sell
48,852
-11,718
-19% -$468K 0.01% 399
2016
Q3 		$2.79M Sell
60,570
-1,285
-2% -$67K 0.02% 311
2016
Q2 		$3.11M Sell
61,855
-3,885
-6% -$207K 0.02% 281
2016
Q1 		$3.52M Sell
65,740
-8,391
-11% -$492K 0.02% 269
2015
Q4 		$4.87M Sell
74,131
-2,258
-3% -$140K 0.03% 245
2015
Q3 		$4.31M Sell
76,389
-2,131
-3% -$138K 0.03% 267
2015
Q2 		$4.64M Sell
78,520
-5,900
-7% -$364K 0.03% 277
2015
Q1 		$5.26M Sell
84,420
-2,287
-3% -$133K 0.03% 263
2014
Q4 		$4.99M Sell
86,707
-7,089
-8% -$395K 0.03% 267
2014
Q3 		$5.04M Sell
93,796
-14,121
-13% -$748K 0.03% 271
2014
Q2 		$5.66M Sell
107,917
-13,060
-11% -$668K 0.04% 249
2014
Q1 		$6.39M Sell
120,977
-37,917
-24% -$1.75M 0.05% 237
2013
Q4 		$6.37M Sell
158,894
-73,529
-32% -$2.9M 0.04% 236
2013
Q3 		$8.78M Sell
232,423
-83,441
-26% -$3.25M 0.06% 203
2013
Q2 		$12.4M Buy
+315,864
New +$12.3M 0.05% 397

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

KeyBank National Association's TEVA Position: Q2 2026 in Review

KeyBank National Association increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 12% in Q2 2026, buying an estimated $71.2K and bringing the position to 20,532 shares worth $696K. The position accounts for ﹤0.01% of the portfolio, ranked #776.

KeyBank National Association first reported a position in TEVA in Q2 2013 and has held it in 22 quarters since. The position peaked at $12.4M in Q2 2013. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • KeyBank National Association held 20,532 shares of Teva Pharmaceutical Industries Limited worth $696K as of Q2 2026.
  • KeyBank National Association bought 2,138 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $71.2K.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #776 holding.
  • KeyBank National Association first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 22 quarters since.
  • KeyBank National Association's Teva Pharmaceutical Industries Limited position peaked at $12.4M in Q2 2013.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.